The scientists already know that the HIV needs specific target cells in the human body to develop properly. More specifically, activated immune cells are more susceptible to HIV than resting cells. A study designed to explore the role of the inflammation in contracting HIV found out that the common aspiring might prevent HIV transmission.
Scientists at the University of Manitoba, in Canada, examined the effect of the common aspirin (acetylsalicylic acid or ASA) in a series of Kenyan women’s HIV target cells.
According to the latest statistics, the HIV incidence is higher among young African women and teen girls across the world, in general.
As reported in the last study, published in the Journal of the International AIDS Society examined the role of inflammation in HIV transmission, and, according to the researchers, the activated immune cells are more susceptible to HIV in comparison to the resting cells. Also, the inflammation is bringing the HIV target cells to the women genital tract, which exposes them more to HIV.
Aspirin might prevent HIV transmission
“Further research is needed to confirm our results with aspirin and test whether this level of target cell reduction will actually prevent HIV infections. If so, this could be a strategy for HIV prevention that is not only inexpensive but easily accessed globally,” explained Keith R. Fowke, a researcher at the University of Manitoba.
The study’s outcomes showed that aspirin is the most-effective anti-inflammatory medication and reduced the HIV target cells incidence in women by 35%.
The purpose of the research was to enhance the array of anti-HIV medication to lower the HIV transmission incidence in the high-risk populations. Besides, the participants in the study stressed they were pleased with the idea that aspirin might fight against HIV, as this drug is commonly used and doesn’t carry the stigma related to other anti-HIV medications.